Virtual Tumor Board solution
Philips' solution transforms and enhances the Tumor Board process. It streamlines preparation, enhances review and analysis, and empowers the cancer care team to reach clinical treatment decisions based upon rich dashboards, reports, and structured patient data. The sessions can be attended virtually or in-person -synchronously or asynchronously.
Services that consistently prove their value
Actionable Flexible tools that can be customized for your assets intuitive and automated workflows. Seamless integration with systems like EMR, pathology, LIMS, and PACS.
Configurable Tailored workflows to capture disease uniqueness.
Predictive Robust dashboards and analytics to enable informed decisions.
Digital Pathology Pathologists are able to open their cases to explain tumor annotations, corresponding quantitative data, and their diagnosis.
Radiology Access radiology images and annotations.
Genomics Genomic biomarker information.
Advanced visualization Advanced visualization for enhanced clinical decision support.
Oncology Pathways In partnership with:
With the exponential growth of clinical trials, it is challenging to consistently keep up with which ones might be beneficial for your patients. In a recent article posted by ASCO, “patients whose physicians participated in tumor boards weekly had an estimated 60% higher odds of enrolling in a clinical trial than patients whose doctors participated less often or never.”1 This is why we have connected all of our tumor boards to the latest clinical trials through advanced clinical trial matching. Your patients matter to us.
1 Post, The ASCO. “Oncologist Participation in Tumor Board Meetings May Be Associated With Improved Outcomes for Patients With Lung or Colorectal Cancers.” ASCO News, Oct. 2014, www.ascopost.com/News/18702.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.